Organ Preservation Market by Solution Type (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) - Global Forecast to 2030

The global organ preservation market is projected to reach USD 0.3 billion by 2030 from USD 0.2 million in 2025, at a CAGR of 6.8% during the forecast period.

The primary objective of organ preservation solutions and devices is to maintain the viability and functionality of organs between procurement and transplantation. Several factors fuel consistent growth in this market, including the increasing volume of organ transplants globally, technological advancements in preservation techniques, and the introduction of specialized solutions such as hypothermic and normothermic machine perfusion systems. The growing incidence of chronic diseases such as end-stage renal and liver failure is driving the demand for organ transplants, which in turn boosts the need for effective preservation technologies.

By solution type, the University of Wisconsin (UW) segment accounted for the largest market share in 2024.

The market is categorized into UW, Custodiol HTK, Perfadex, and other solutions by solution type. In 2024, the University of Wisconsin (UW) solution accounted for the largest market share owing to high adoption and features such as proven efficacy in preserving organs like the liver, kidneys, and pancreas. It was the first introduced intracellular preservation solution and is widely regarded as the global benchmark for organ preservation. Its established clinical outcomes and reliability have solidified its position as the preferred choice among transplant surgeons and healthcare facilities.

By technique, the normothermic machine perfusion segment is expected to register the highest CAGR during the forecast period.

The normothermic machine perfusion segment is expected to grow at the highest CAGR during the forecast period. This technique simulates natural physiological conditions by maintaining normal body temperature and supplying essential nutrients and oxygen to the organ. It supports cellular function and metabolism throughout the preservation period. Normothermic perfusion helps maintain organ viability and minimizes inflammatory responses and ischemic injury, particularly in liver transplants. It is vital in improving graft regeneration and has been associated with better outcomes in transplant cases involving extended criteria donors, such as older individuals or those with comorbidities. As a result, its relevance is growing among transplant professionals seeking to optimize long-term graft survival and function.

By organ type, the lungs segment is expected to grow at the highest CAGR during the forecast period.

The lungs segment is expected to grow at the highest CAGR during the forecast period. Lung transplantation is regarded as the preferred treatment for patients with end-stage lung diseases such as chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, or cystic fibrosis, all of which contribute to the growth of this segment. Other common causes of end-stage lung disease in adult patients include alpha-1 antitrypsin deficiency and pulmonary hypertension. With the increasing prevalence of respiratory illnesses, the number of patients requiring lung transplants is anticipated to rise, thereby driving demand for lung transplants. Additionally, advancements in graft survival and long-term graft function have established lung transplantation as a vital and often life-saving therapeutic option.

By end user, the specialty clinics segment is expected to grow at the highest CAGR during the forecast period.

The organ preservation market is segmented by end-users into organ transplant centers, hospitals, and specialty clinics. The specialty clinics segment is projected to grow at the highest CAGR in the organ preservation market due to their increasing role in transplant procedures and post-operative care. These clinics offer focused expertise, faster turnaround times, and advanced technologies tailored to organ preservation needs. Additionally, growing patient preference for specialized care and the rise in private healthcare investments further accelerate their growth in this segment.

By region, the Asia Pacific is expected to grow at the highest CAGR during the forecast period.

The Asia Pacific region is projected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is primarily attributed to the combination of favorable government policies, increased public awareness, and a higher number of organ donations. For instance, China has seen its donation rates improve thanks to intensified public education, mobilization efforts, and technological advancements in organ transplants. Meanwhile, India's rapid development in healthcare infrastructure has supported market growth and fostered medical tourism. Even with religious considerations, Japan has observed an improvement in organ donation due to a higher willingness to donate organs.

The breakdown of primary participants was as mentioned below:

  • By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
  • By Designation – C-level–35%, Director-level–25%, Others–40%
  • By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, the Middle East & Africa–1%, and GCC countries—1%
Key Players in the Organ Preservation Market

The key players operating in the organ preservation market include Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), and TX Innovations (Netherlands).

Research Coverage:

The report analyzes the organ preservation market and aims to estimate the market size and future growth potential based on various segments such as solution, technique, organ type, end user, and region. The report also includes a product portfolio matrix of various organ preservation products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which in turn would help them garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

Analysis of key drivers (Ascending cases of multiple organ failure and growth in the geriatric population, the increasing initiatives to promote public awareness and encourage organ donation, the rising number of organ donors boost adoption of solid organ transplantation procedures); restraints (High cost of organ transplantation and religious concerns and misconceptions associated to organ donation); opportunities (the increasing focus on healthcare investments); and challenges (Significant gap between the number of organs donated and organs required annually coupled with the development of artificial organs)
  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global organ preservation market. The report analyzes this market by solution, technique, organ type, and end user.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global organ preservation market
  • Market Development: Comprehensive information on the lucrative emerging markets by solution type, technique, organ type, and end user
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global organ preservation market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global organ preservation market.


Tables List
Table 1 Exchange Rates Utilized For Conversion To Usd, 2021–2024
Table 2 Growth In Geriatric Population (Above 65 Age Group), By Region,
2019 Vs. 2050 (Million)
Table 3 Number Of Organ Donations, 2020
Table 4 Cost Of Surgical Procedures: Us Vs. India (Usd)
Table 5 Average Selling Price Range Of Organ Preservation Solutions,
By Key Players, 2023–2024
Table 6 Average Selling Price Range Of Custodiol Solutions For Organ Preservation Solutions In Key Regions, 2022–2024
Table 7 Organ Preservation Market: List Of Major Patents, 2020–2021
Table 8 Import Data Of Organ Preservation For Hs Code 300640, By Country, 2019–2023 (Usd Thousand)
Table 9 Export Data Of Organ Preservation For Hs Code 300640, By Country, 2019–2023 (Usd Thousand)
Table 10 North America: Regulatory Bodies, Government Agencies, And Other Organizations
Table 11 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations
Table 12 Latin America: Regulatory Bodies, Government Agencies, And Other Organizations
Table 13 Rest Of The World: Regulatory Bodies, Government Agencies, And Other Organizations
Table 14 Influence Of Stakeholders On Buying Process For Top 3 Solutions (%)
Table 15 Key Buying Criteria For Top 3 Solutions
Table 16 Case Study 1: Preservation Of Marginal Liver Using Normothermic Machine Perfusion (Nmp)
Table 17 Case Study 2: Hypothermic Machine Perfusion For Extended Criteria Kidney Transplant
Table 18 Case Study 3: Use Of Portable Normothermic Perfusion For Heart Transplantation
Table 19 Us-adjusted Reciprocal Tariff Rates
Table 20 Organ Preservation Market, By Solution, 2023–2030 (Usd Million)
Table 21 Organ Preservation Solutions Market, By Country/Region,
2023–2030 (Usd Million)
Table 22 Organ Preservation Market For Uw Solutions, By Country/Region, 2023–2030 (Usd Million)
Table 23 Organ Preservation Market For Custodiol Htk Solutions, By Country/ Region, 2023–2030 (Usd Million)
Table 24 Organ Preservation Market For Perfadex Solutions,
By Country/Region, 2023–2030 (Usd Million)
Table 25 Other Organ Preservation Solutions Market, By Country/Region, 2023–2030 (Usd Million)
Table 26 Comparison Of Methods Used For Organ Preservation
Table 27 Organ Preservation Market, By Technique, 2023–2030 (Usd Million)
Table 28 Organ Preservation Technique Market, By Country/Region,
2023–2030 (Usd Million)
Table 29 Static Cold Storage: Advantages And Disadvantages
Table 30 Organ Preservation Market For Static Cold Storage,
By Country/Region, 2023–2030 (Usd Million)
Table 31 Hypothermic Machine Perfusion: Advantages And Disadvantages
Table 32 Organ Preservation Market For Hypothermic Machine Perfusion,
By Country/Region, 2023–2030 (Usd Million)
Table 33 Normothermic Machine Perfusion: Advantages And Disadvantages
Table 34 Organ Preservation Market For Normothermic Machine Perfusion,
By Country/Region, 2023–2030 (Usd Million)
Table 35 Organ Preservation Market, By Organ Type, 2023–2030 (Usd Million)
Table 36 Kidney Preservation Market, By Country/Region,
2023–2030 (Usd Million)
Table 37 Liver Preservation Market, By Country/Region,
2023–2030 (Usd Million)
Table 38 Lung Preservation Market, By Country/Region,
2023–2030 (Usd Million)
Table 39 Heart Preservation Market, By Country/Region,
2023–2030 (Usd Million)
Table 40 Other Organ Preservation Market, By Country/Region,
2023–2030 (Usd Million)
Table 41 Organ Preservation Market, By End User, 2023–2030 (Usd Million)
Table 42 Organ Preservation Market For Organ Transplant Centers,
By Country/Region, 2023–2030 (Usd Million)
Table 43 Organ Preservation Market For Hospitals, By Country/Region,
2023–2030 (Usd Million)
Table 44 Organ Preservation Market For Specialty Clinics, By Country/Region, 2023–2030 (Usd Million)
Table 45 Organ Preservation Market, By Region, 2023–2030 (Usd Million)
Table 46 North America: Organ Preservation Market, By Country,
2023–2030 (Usd Million)
Table 47 North America: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 48 North America: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 49 North America: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 50 North America: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 51 Us: Key Macroindicators
Table 52 Waiting List For Organ Transplants As Of January 2022
Table 53 Us: Organ Preservation Market, By Technique, 2023–2030 (Usd Million)
Table 54 Us: Organ Preservation Market, By Solution, 2023–2030 (Usd Million)
Table 55 Us: Organ Preservation Market, By Organ Type, 2023–2030 (Usd Million)
Table 56 Us: Organ Preservation Market, By End User, 2023–2030 (Usd Million)
Table 57 Canada: Key Macroindicators
Table 58 Canada: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 59 Canada: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 60 Canada: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 61 Canada: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 62 Europe: Organ Preservation Market, By Country,
2023–2030 (Usd Million)
Table 63 Europe: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 64 Europe: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 65 Europe: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 66 Europe: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 67 Germany: Key Macroindicators
Table 68 Germany: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 69 Germany: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 70 Germany: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 71 Germany: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 72 France: Key Macroindicators
Table 73 France: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 74 France: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 75 France: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 76 France: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 77 Uk: Key Macroindicators
Table 78 Total Number Of Patients On Active Organ Transplant Waiting List In
Uk (As Of April 8, 2021)
Table 79 Uk: Organ Preservation Market, By Technique, 2023–2030 (Usd Million)
Table 80 Uk: Organ Preservation Market, By Solution, 2023–2030 (Usd Million)
Table 81 Uk: Organ Preservation Market, By Organ Type, 2023–2030 (Usd Million)
Table 82 Uk: Organ Preservation Market, By End User, 2023–2030 (Usd Million)
Table 83 Spain: Key Macroindicators
Table 84 Spain: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 85 Spain: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 86 Spain: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 87 Spain: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 88 Italy: Key Macroindicators
Table 89 Italy: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 90 Italy: Organ Preservation Market, By Solution, 2023–2030 (Usd Million)
Table 91 Italy: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 92 Italy: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 93 Rest Of Europe: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 94 Rest Of Europe: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 95 Rest Of Europe: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 96 Rest Of Europe: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 97 Asia Pacific: Organ Preservation Market, By Country,
2023–2030 (Usd Million)
Table 98 Asia Pacific: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 99 Asia Pacific: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 100 Asia Pacific: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 101 Asia Pacific: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 102 China: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 103 China: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 104 China: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 105 China: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 106 Total Number Of Patients On Organ Transplant Waiting List In Japan (As Of March 31, 2021)
Table 107 Japan: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 108 Japan: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 109 Japan: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 110 Japan: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 111 India: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 112 India: Organ Preservation Market, By Solution, 2023–2030 (Usd Million)
Table 113 India: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 114 India: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 115 Australia: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 116 Australia: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 117 Australia: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 118 Australia: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 119 South Korea: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 120 South Korea: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 121 South Korea: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 122 South Korea: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 123 Rest Of Asia Pacific: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 124 Rest Of Asia Pacific: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 125 Rest Of Asia Pacific: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 126 Rest Of Asia Pacific: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 127 Latin America: Organ Preservation Market, By Country,
2023–2030 (Usd Million)
Table 128 Latin America: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 129 Latin America: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 130 Latin America: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 131 Latin America: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 132 Brazil: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 133 Brazil: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 134 Brazil: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 135 Brazil: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 136 Mexico: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 137 Mexico: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 138 Mexico: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 139 Mexico: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 140 Rest Of Latin America: Organ Preservation Market, By Technique, 2023–2030 (Usd Million)
Table 141 Rest Of Latin America: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 142 Rest Of Latin America: Organ Preservation Market, By Organ Type, 2023–2030 (Usd Million)
Table 143 Rest Of Latin America: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 144 Middle East & Africa: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 145 Middle East & Africa: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 146 Middle East & Africa: Organ Preservation Market, By Organ Type, 2023–2030 (Usd Million)
Table 147 Middle East & Africa: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 148 Gcc Countries: Organ Preservation Market, By Technique,
2023–2030 (Usd Million)
Table 149 Gcc Countries: Organ Preservation Market, By Solution,
2023–2030 (Usd Million)
Table 150 Gcc Countries: Organ Preservation Market, By Organ Type,
2023–2030 (Usd Million)
Table 151 Gcc Countries: Organ Preservation Market, By End User,
2023–2030 (Usd Million)
Table 152 Overview Of Strategies Adopted By Players In Organ Preservation Market
Table 153 Organ Preservation Market: Degree Of Competition
Table 154 Organ Preservation Market: Solution Footprint
Table 155 Organ Preservation Market: Technique Footprint
Table 156 Organ Preservation Market: End User Footprint
Table 157 Organ Preservation Market: Region Footprint
Table 158 Organ Preservation Market: List Of Key Startups/Smes
Table 159 Organ Preservation Market: Competitive Benchmarking Of Key Startups/Smes
Table 160 Organ Preservation Market: Product Launches & Approvals,
January 2021–june 2025
Table 161 Organ Preservation Market: Deals, January 2021–june 2025
Table 162 Organ Preservation Market: Other Developments,
January 2021–june 2025
Table 163 Paragonix Technologies, Inc.: Company Overview
Table 164 Paragonix Technologies, Inc.: Products Offered
Table 165 Paragonix Technologies, Inc.: Product Launches,
January 2021–may 2025
Table 166 Paragonix Technologies, Inc.: Deals, January 2021–may 2025
Table 167 Paragonix Technologies, Inc.: Other Developments,
January 2021–may 2025
Table 168 Xvivo Perfusion Ab: Company Overview
Table 169 Xvivo Perfusion Ab: Products Offered
Table 170 Xvivo Perfusion Ab: Product Launches & Approvals,
January 2021–may 2025
Table 171 Xvivo Perfusion Ab: Deals, January 2021–may 2025
Table 172 Dr. Franz Köhler Chemie Gmbh: Company Overview
Table 173 Dr. Franz Köhler Chemie Gmbh: Products Offered
Table 174 Essential Pharmaceuticals, Llc: Company Overview
Table 175 Essential Pharmaceuticals, Llc: Products Offered
Table 176 Transmedics, Inc.: Company Overview
Table 177 Transmedics, Inc.: Products Offered
Table 178 Transmedics, Inc.: Product Launches & Approvals
Table 179 Transmedics, Inc.: Deals
Table 180 Organox Limited: Company Overview
Table 181 Organox Limited: Products Offered
Table 182 Organox Limited: Product Launches & Approvals
Table 183 Organox Limited: Deals
Table 184 21st Century Medicine: Company Overview
Table 185 21st Century Medicine: Products Offered
Table 186 Biolife Solutions, Inc.: Company Overview
Table 187 Biolife Solutions, Inc.: Products Offered
Table 188 Biolife Solutions, Inc.: Product Launches, January 2021–may 2025
Table 189 Biolife Solutions, Inc.: Deals, January 2021–may 2025
Table 190 Bridge To Life Limited: Company Overview
Table 191 Bridge To Life Limited: Products Offered
Table 192 Bridge To Life Limited: Product Launches & Approvals,
January 2021–may 2025
Table 193 Bridge To Life Limited: Deals, January 2021–may 2025
Table 194 Waters Medical Systems Llc: Company Overview
Table 195 Waters Medical Systems Llc: Products Offered
Figures List
Figure 1 Organ Preservation Market: Research Design
Figure 2 List Of Primary Sources
Figure 3 Breakdown Of Primary Interviews: Supply-side And Demand-side Participants
Figure 4 Breakdown Of Primary Interviews (Supply Side): By Company Type, Designation, And Region
Figure 5 Breakdown Of Primary Interviews (Demand Side): By Company Type, Designation, And Region
Figure 6 Supply-side Market Size Estimation: Revenue Share Analysis
Figure 7 Revenue Share Analysis Illustration: Xvivo Perfusion Ab (2024)
Figure 8 Illustrative Example Of Procedure-based Market Estimation
Figure 9 Supply-side Market Size Estimation: Organ Preservation Market (2024)
Figure 10 Top-down Approach
Figure 11 Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges In Organ Preservation Market (2025–2030)
Figure 12 Cagr Projections: Supply-side Analysis
Figure 13 Data Triangulation Methodology
Figure 14 Organ Preservation Market, By Solution, 2025 Vs. 2030 (Usd Million)
Figure 15 Organ Preservation Market, By Technique, 2025 Vs. 2030 (Usd Million)
Figure 16 Organ Preservation Market, By Organ Type, 2025 Vs. 2030 (Usd Million)
Figure 17 Organ Preservation Market, By End User, 2025 Vs. 2030 (Usd Million)
Figure 18 Geographic Analysis Of Organ Preservation Market
Figure 19 Rising Number Of Solid Organ Transplants To Drive Organ Preservation Market
Figure 20 University Of Wisconsin Solution And China Segments Accounted For Largest Share Of Asia Pacific Organ Preservation Market In 2024
Figure 21 China To Register Fastest Growth During Forecast Period
Figure 22 North America To Dominate Organ Preservation Market Till 2030
Figure 23 Emerging Markets To Register Higher Growth Rates During Forecast Period
Figure 24 Organ Preservation Market: Drivers, Restraints, Opportunities,
And Challenges
Figure 25 Organ Preservation Market: Ecosystem Analysis
Figure 26 Organ Preservation Market: Value Chain Analysis
Figure 27 Supply Chain Analysis: Organ Preservation Market (2024)
Figure 28 Top Patent Applicants And Owners (Companies/Institutes) For Organ Preservation Solutions (January 2014–april 2025)
Figure 29 Jurisdiction Analysis: Top Applicant Countries For Organ Preservation Patents, 2014–2025
Figure 30 Organ Preservation Market: Porter’s Five Forces Analysis
Figure 31 Influence Of Stakeholders On Buying Process For Top 3 Solutions
Figure 32 Key Buying Criteria For Top 3 Solutions
Figure 33 Trends And Disruptions Disrupting Customer Business In Organ Preservation Market
Figure 34 Organ Preservation Market: Investment And Funding Scenario,
2021–2024
Figure 35 Organ Preservation Market: Ai Integration
Figure 38 Asia Pacific: Organ Preservation Market Snapshot
Figure 39 Revenue Analysis Of Key Players In Organ Preservation Market (2021−2024)
Figure 40 Market Share Analysis Of Key Players (2024)
Figure 41 Organ Preservation Market: Company Evaluation Matrix
(Key Players), 2024
Figure 42 Organ Preservation Market: Company Footprint
Figure 43 Organ Preservation Market: Company Evaluation Matrix (Startups/Smes), 2024
Figure 44 Year-to-date (Ytd) Price, Total Return, And 5-year Stock Beta Of
Key Vendors
Figure 45 Ev/Ebitda Of Key Vendors
Figure 46 Organ Preservation Market: Brand/Product Comparative Analysis
Figure 47 Xvivo Perfusion Ab: Company Snapshot (2024)
Figure 48 Transmedics, Inc.: Company Snapshot (2024)
Figure 49 Biolife Solutions, Inc.: Company Snapshot (2024)

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions And Exclusions
1.3 Market Scope
1.3.1 Market Segmentation & Regional Scope
1.3.2 Years Considered
1.4 Currency Considered
1.5 Summary Of Changes
2 Research Methodology
2.1 Research Approach
2.2 Research Design
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Data
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation
2.4 Market Breakdown & Data Triangulation
2.5 Market Ranking Analysis
2.6 Research Assumptions
2.7 Research Limitations
2.7.1 Methodology-related Limitations
2.7.2 Scope-related Limitations
2.8 Risk Assessment
3 Executive Summary
4 Premium Insights
4.1 Attractive Opportunities For Players In Organ Preservation Market
4.2 Asia Pacific: Organ Preservation Market, By Solution And Country
4.3 Organ Preservation Market: Geographic Growth Opportunities
4.4 Organ Preservation Market, By Region, 2023–2030
4.5 Organ Preservation Market: Developed Vs. Emerging Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Geriatric Population And Subsequent Growth In Cases Of Multiple Organ Failure
5.2.1.2 Increasing Initiatives To Promote Public Awareness And Encourage Organ Donation
5.2.1.3 Rising Number Of Organ Donors And Growing Adoption Of Solid Organ Transplantation Procedures
5.2.2 Restraints
5.2.2.1 High Cost Of Organ Transplantation
5.2.2.2 Religious Concerns And Misconceptions Associated With Organ Donation
5.2.3 Opportunities
5.2.3.1 Growing Healthcare Investments
5.2.4 Challenges
5.2.4.1 Significant Gap Between Number Of Organs Donated And Organs Required Annually
5.2.4.2 Development Of Artificial Organs
5.3 Ecosystem Analysis
5.4 Value Chain Analysis
5.5 Pricing Analysis
5.6 Supply Chain Analysis
5.7 Patent Analysis
5.7.1 Patent Publication Trends For Organ Preservation Market
5.7.2 Top Applicants (Companies) Of Organ Preservation Patents
5.7.3 Jurisdiction Analysis: Top Applicants (Countries) For Patents In Organ Preservation Market
5.8 Technology Analysis
5.8.1 Key Technologies
5.8.1.1 Machine Perfusion
5.8.1.2 Organ Perfusion
5.8.2 Adjacent Technologies
5.8.2.1 Cryopreservation & Vitrification
5.8.3 Complementary Technologies
5.8.3.1 Temperature Monitoring Devices
5.9 Trade Analysis
5.9.1 Import Data
5.9.2 Export Data
5.10 Key Conferences And Events In 2025–2026
5.11 Regulatory Landscape
5.11.1 Regulatory Analysis
5.11.1.1 North America
5.11.1.1.1 Us
5.11.1.1.2 Canada
5.11.1.2 Europe
5.11.1.3 Asia Pacific
5.11.1.3.1 China
5.11.1.3.2 Japan
5.11.1.3.3 India
5.11.1.4 Latin America
5.11.1.4.1 Brazil
5.11.1.4.2 Mexico
5.11.1.5 Middle East
5.11.1.6 Africa
5.11.2 Regulatory Bodies, Government Agencies, And Other Organizations
5.12 Porter’s Five Forces Analysis
5.12.1 Threat From New Entrants
5.12.2 Threat From Substitutes
5.12.3 Bargaining Power Of Suppliers
5.12.4 Bargaining Power Of Buyers
5.12.5 Intensity Of Competitive Rivalry
5.13 Key Stakeholders And Buying Criteria
5.13.1 Key Stakeholders In Buying Process
5.13.2 Buying Criteria
5.14 Trends/Disruptions Impacting Customer Business
5.15 Case Study Analysis
5.16 Investment And Funding Scenario
5.17 Reimbursement Scenario
5.18 Impact Of Ai On Organ Preservation Market
5.19 End User Expectations In Organ Preservation Market
5.20 Impact Of 2025 Us Tariffs
5.20.1 Introduction
5.20.2 Key Tariff Rates
5.20.3 Price Impact Analysis
5.20.4 Impact On End Users
6 Organ Preservation Market, By Solution
6.1 Introduction
6.2 University Of Wisconsin
6.2.1 Metabolically Inert Substrates Enable Better Transplantation Outcomes
6.3 Custodiol Htk
6.3.1 Indicated For Perfusion And Flushing Of Kidneys, Liver, Pancreas, And Heart
6.4 Perfadex
6.4.1 Launch Of Perfadex Plus To Drive Market
6.5 Other Solutions
7 Organ Preservation Market, By Technique
7.1 Introduction
7.2 Static Cold Storage
7.2.1 Most Widely Adopted Organ Preservation Technique
7.3 Hypothermic Machine Perfusion
7.3.1 Advantages Associated With Hypothermic Machine Perfusion To Drive Demand
7.4 Normothermic Machine Perfusion
7.4.1 Provides Viable Environment For Organ Preservation, Viability, And Repair Prior To Transplantation
8 Organ Preservation Market, By Organ Type
8.1 Introduction
8.2 Kidneys
8.2.1 Most Transplanted Organs Globally
8.3 Liver
8.3.1 Rising Prevalence Of Liver Disease And Growing Cases Of Liver Failure To Drive Demand For Liver Transplantation Procedures
8.4 Lungs
8.4.1 Growth In Copd Incidence To Boost Demand For Preservation Techniques And Products
8.5 Heart
8.5.1 Advancements In Heart Preservation Techniques To Drive Market
8.6 Other Organs
9 Organ Preservation Market, By End User
9.1 Introduction
9.2 Organ Transplant Centers
9.2.1 Major End Users Of Organ Preservation Solutions
9.3 Hospitals
9.3.1 Increasing Cases Of Accidental Injuries And Chronic Diseases To Drive Market
9.4 Specialty Clinics
9.4.1 Increasing Prevalence Of End-stage Diseases And Organ Failure To Drive Market
10 Organ Preservation Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Macroeconomic Outlook
10.2.2 Us
10.2.2.1 Growing Cases Of Organ Failure And Underlying Diseases To Drive Demand
10.2.3 Canada
10.2.3.1 Improved Organ Donation Rates To Drive Growth
10.3 Europe
10.3.1 Macroeconomic Outlook
10.3.2 Germany
10.3.2.1 Growing Patient Population To Drive Demand
10.3.3 France
10.3.3.1 Increasing Number Of Organ Transplants And Organ Donor Registrations To Drive Growth
10.3.4 Uk
10.3.4.1 Increasing Disease/Disorder Prevalence And Favorable Regulations To Drive Demand
10.3.5 Spain
10.3.5.1 High Donation Rates To Drive Growth
10.3.6 Italy
10.3.6.1 Surge In Donor Numbers And Technological Innovation To Drive Growth
10.3.7 Rest Of Europe
10.4 Asia Pacific
10.4.1 Macroeconomic Outlook
10.4.2 China
10.4.2.1 Growing Awareness And Adoption Of Laws Favoring Organ Donation To Drive Market
10.4.3 Japan
10.4.3.1 Nationwide Awareness Campaigns And Promoted Opt-in Registration To Drive Growth
10.4.4 India
10.4.4.1 Growing Number Of Initiatives To Increase Public Awareness To Drive Market
10.4.5 Australia
10.4.5.1 Enhanced Hospital-based Donation Programs To Drive Growth
10.4.6 South Korea
10.4.6.1 Improved Donor Registration Systems To Drive Growth
10.4.7 Rest Of Asia Pacific
10.5 Latin America
10.5.1 Macroeconomic Outlook
10.5.2 Brazil
10.5.2.1 Digitalization Of Donor Registries To Drive Growth
10.5.3 Mexico
10.5.3.1 Organ Donation Efforts Supported By Centralized Transplant Registry And National Coordination To Drive Growth
10.5.4 Rest Of Latin America
10.6 Middle East & Africa
10.6.1 Implementation Of Government Initiatives And Policies To Drive Market
10.6.2 Macroeconomic Outlook
10.7 Gcc Countries
10.7.1 Strong Organ Preservation Through Incentives, Infrastructure, And Public Awareness To Drive Growth
10.7.2 Macroeconomic Outlook
11 Competitive Landscape
11.1 Overview
11.2 Key Player Strategies/Right To Win
11.3 Revenue Analysis, 2022–2024
11.4 Market Share Analysis
11.5 Company Evaluation Matrix: Key Players, 2024
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Company Footprint: Key Players, 2024
11.5.5.1 Company Footprint
11.5.5.2 Solution Footprint
11.5.5.3 Technique Footprint
11.5.5.4 End User Footprint
11.5.5.5 Region Footprint
11.6 Company Evaluation Matrix: Startups/Smes, 2024
11.6.1 Progressive Companies
11.6.2 Responsive Companies
11.6.3 Dynamic Companies
11.6.4 Starting Blocks
11.6.5 Competitive Benchmarking: Startups/Smes, 2024
11.6.5.1 List Of Key Startups/Smes
11.6.5.2 Competitive Benchmarking Of Key Startups/Smes
11.7 Company Valuation And Financial Metrics
11.7.1 Company Valuation
11.7.2 Financial Metrics
11.8 Brand/Product Comparison
11.9 Competitive Scenario
11.9.1 Product Launches & Approvals
11.9.2 Deals
11.9.3 Other Developments
12 Company Profiles
12.1 Key Players
12.1.1 Paragonix Technologies, Inc.
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Recent Developments
12.1.1.3.1 Product Launches
12.1.1.3.2 Deals
12.1.1.3.3 Other Developments
12.1.1.4 Mnm View
12.1.1.4.1 Right To Win
12.1.1.4.2 Strategic Choices
12.1.1.4.3 Weaknesses And Competitive Threats
12.1.2 Xvivo Perfusion Ab
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Product Launches & Approvals
12.1.2.3.2 Deals
12.1.2.4 Mnm View
12.1.2.4.1 Right To Win
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses And Competitive Threats
12.1.3 Dr. Franz Köhler Chemie Gmbh
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Mnm View
12.1.3.3.1 Right To Win
12.1.3.3.2 Strategic Choices
12.1.3.3.3 Weaknesses And Competitive Threats
12.1.4 Essential Pharmaceuticals, Llc (Subsidiary Of Accord Healthcare)
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Mnm View
12.1.4.3.1 Right To Win
12.1.4.3.2 Strategic Choices
12.1.4.3.3 Weaknesses And Competitive Threats
12.1.5 Transmedics, Inc.
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Product Launches & Approvals
12.1.5.3.2 Deals
12.1.5.4 Mnm View
12.1.5.4.1 Right To Win
12.1.5.4.2 Strategic Choices
12.1.5.4.3 Weaknesses And Competitive Threats
12.1.6 Organox Limited
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.6.3 Recent Developments
12.1.6.3.1 Product Launches & Approvals
12.1.6.3.2 Deals
12.1.7 21st Century Medicine
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.8 Biolife Solutions, Inc.
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.8.3 Recent Developments
12.1.8.3.1 Product Launches
12.1.8.3.2 Deals
12.1.9 Bridge To Life Limited
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Product Launches & Approvals
12.1.9.3.2 Deals
12.1.10 Waters Medical Systems Llc
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.2 Other Players
12.2.1 Shanghai Genext Medical Technology Co., Ltd.
12.2.2 Preservation Solutions, Inc.
12.2.3 Carnamedica
12.2.4 Transplant Biomedicals
12.2.5 Institut Georges Lopez
12.2.6 Global Transplant Solutions
12.2.7 Avionord
12.2.8 Organ Preservation Solutions Ltd.
12.2.9 Ebers
12.2.10 S.A.L.F.
12.2.11 Biochefa
12.2.12 Vascular Perfusion Solutions, Inc.
12.2.13 Tx Innovations
12.2.14 Taiyo Nippon Sanso Corporation
12.2.15 X-therma, Inc.
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings